Literature DB >> 8943750

Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis.

D Y Graham1, R M Genta, D P Graham, J E Crabtree.   

Abstract

AIM/
BACKGROUND: Several studies have suggested that Helicobacter pylori which express CagA may be more virulent than those that do not, but limited populations have been studied to date. The aim of this study was to confirm and extend the association of CagA positive H pylori strains in a different geographical area and to a large, well defined patient population.
METHOD: A validated ELISA for serum IgG to CagA was used to investigate the prevalence of CagA seropositivity in 100 patients with peptic ulcer compared with 77 with H pylori infection without ulcer disease in a North American population. The extent of antral and corpus inflammation and H pylori density in relation to CagA seropositivity in 40 subjects with H pylori infection were assessed semiquanitatively. All studies were carried out in a coded and blinded manner.
RESULTS: The prevalence of serum IgG CagA antibodies was higher in H pylori infected patients with ulcer (59%) compared with healthy H pylori infected volunteers (44%), but the difference was not significant. In contrast, the titre of serum IgG anti-CagA antibodies was higher among the seropositive subjects without ulcer disease, but again the difference was not significant. Comparison of histological features between asymptomatic individuals with H pylori infection in relation to CagA IgG antibody status revealed no differences in infiltration with acute inflammatory cells, H pylori density, or gastritis index. There was no relation evident between the degree of polymorphonuclear cell infiltration and the serum IgG antibody titre to CagA. Mononuclear cell infiltration in the antrum, but not the corpus, was greater in those with CagA IgG compared with those without (median score 5 v 3).
CONCLUSIONS: A right association between the presence or titre of serum IgG to CagA and peptic ulcer disease, greater H pylori density or infiltration of the mucosa with acute inflammatory cells could not confirmed in a North American population. Perhaps geographical differences in the prevalence of circulating H pylori strains are responsible for the discrepant results reported.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943750      PMCID: PMC500778          DOI: 10.1136/jcp.49.10.829

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity.

Authors:  G J LaRosa; K M Thomas; M E Kaufmann; R Mark; M White; L Taylor; G Gray; D Witt; J Navarro
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

2.  Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only.

Authors:  N Figura; P Guglielmetti; A Rossolini; A Barberi; G Cusi; R A Musmanno; M Russi; S Quaranta
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

4.  Antibody to cytotoxin in infection by Helicobacter pylori.

Authors:  R D Leunk; M A Ferguson; D R Morgan; D E Low; A E Simor
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

5.  Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells.

Authors:  M K Tummuru; S A Sharma; M J Blaser
Journal:  Mol Microbiol       Date:  1995-12       Impact factor: 3.501

6.  Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production.

Authors:  M K Tummuru; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.

Authors:  T L Cover; C P Dooley; M J Blaser
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

8.  Laboratory testing on cerebrospinal fluid. A reappraisal.

Authors:  R A Hayward; M F Shapiro; R K Oye
Journal:  Lancet       Date:  1987-01-03       Impact factor: 79.321

9.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

View more
  27 in total

Review 1.  Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development.

Authors:  Y Zevering; L Jacob; T F Meyer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Incidence of Helicobacter pylori infection in a cohort of Italian military students.

Authors:  R Biselli; M Fortini; P M Matricardi; T Stroffolini; R D'Amelio
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

3.  Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.

Authors:  M Donati; S Moreno; E Storni; A Tucci; L Poli; C Mazzoni; O Varoli; V Sambri; A Farencena; R Cevenini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

4.  Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer.

Authors:  F Fraggetta; E Vasquez; A Granata; P Fatuzzo; F Rapisarda; N Figura
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

5.  CagA antibodies in Japanese children with nodular gastritis or peptic ulcer disease.

Authors:  S Kato; T Sugiyama; M Kudo; K Ohnuma; K Ozawa; K Iinuma; M Asaka; M J Blaser
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Clinical outcome after infection with Helicobacter pylori does not appear to be reliably predicted by the presence of any of the genes of the cag pathogenicity island.

Authors:  P J Jenks; F Mégraud; A Labigne
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

7.  Identification of cagA tyrosine phosphorylation DNA motifs in Helicobacter pylori isolates from peptic ulcer patients by novel PCR-restriction fragment length polymorphism and real-time fluorescence PCR assays.

Authors:  Robert J Owen; Sally I Sharp; Stephanie A Chisholm; Sjoerd Rijpkema
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Microflora of gastric biopsies from patients with duodenal ulcer and gastric cancer: a comparative study of patients from Korea, Colombia, and the United States.

Authors:  M S Osato; O Gutierrez; J G Kim; G Steinbach; D Y Graham
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

9.  Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway.

Authors:  Rena J Menaker; Peter J M Ceponis; Nicola L Jones
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  CagA and VacA Helicobacter pylori antibodies in gastric cancer.

Authors:  R Suriani; M Colozza; E Cardesi; D Mazzucco; M Marino; S Grosso; S Sanseverinati; I Venturini; A Borghi; M Luisa Zeneroli
Journal:  Can J Gastroenterol       Date:  2008-03       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.